An Overview of Hypertensive States During Pregnancy for Primary Care Physicians
Main Article Content
Abstract
With the aim of informing the first contact physician about the hypertensive states of pregnancy, we carried out this bibliographic review. Sources in English and Spanish were consulted for the writing of this article. Hypertensive status of pregnancy refers to a group of disorders that constitute, as a group, one of the most common complications of pregnancy [1]. The incidence of this group of disorders is close to 1 in 10 pregnant women [2], due to its high frequency, it is important for all doctors to know about these states, for their early identification, particular diagnostic method to each of them and the treatment of choice. Thus through prevention at the first level of care and its treatment at the second level of care, the incidence of both maternal and perinatal complications is reduced, generating a benefit to the Mexican public health.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol [Internet]. 2020;135(6):e237–60. Disponible en: http://dx.doi.org/10.1097/aog.0000000000003891
II. Lo JO, Mission JF, Caughey AB. Hypertensive disease of pregnancy and maternal mortality. Curr Opin Obstet Gynecol [Internet]. 2013;25(2):124–32. Available from:http://dx.doi.org/10.1097/gco.0b013e32835e0ef5
III. Organización Panamericana de la Salud. Synthesis of evidence and recommendations for the management of calcium supplementation before and during pregnancy for the prevention of preeclampsia and its complications. Rev Panam Salud Publica [Internet]. 2021;45:e134. Disponible en: http://dx.doi.org/10.26633/RPSP.2021.134
IV. World Health Organization. Recomendaciones de la Oms Para La Prevención Y El Tratamiento de la Preeclampsia y Eclampsia. World Health Organization; 2014.
V. Mayrink J, Costa ML, Cecatti JG. Preeclampsia in 2018: Revisiting concepts, physiopathology, and prediction. ScientificWorldJournal [Internet]. 2018; 2018:6268276. Disponible en: http://dx.doi.org/10.1155/2018/6268276
VI. Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. The Lancet. 2001.
VII. Karumanchi SA, Levine RJ. How does smoking reduce the risk of preeclampsia? Hypertension [Internet]. 2010;55(5):1100–1. Available from: http://dx.doi.org/10.1161/hypertensionaha.109.148973
VIII. Flickr F us on. About preeclampsia and eclampsia [Internet]. https://www.nichd.nih.gov/. [cited 2022 Aug 2]. Available from:
https://www.nichd.nih.gov/health/topics/preeclampsia/conditioninfo
IX. Powles K, Gandhi S. Postpartum hypertension. CMAJ [Internet]. 2017;189(27):E913–E913. Available from: http://dx.doi.org/10.1503/cmaj.160785
X. Bramham K, Nelson-Piercy C, Brown MJ, Chappell LC. Postpartum management of hypertension. BMJ [Internet]. 2013;346(feb25 1):f894–f894. Available from: http://dx.doi.org/10.1136/bmj.f894
XI. Leeman L, Dresang LT, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician. 2016;93(2):121–7.
XII. Hladunewich M, Karumanchi SA, Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. Clin J Am Soc Nephrol [Internet]. 2007;2(3):543–9. Available from:
http://dx.doi.org/10.2215/cjn.03761106
XIII. Haram K, Mortensen JH, Nagy B. Genetic aspects of preeclampsia and the HELLP syndrome. J Pregnancy [Internet]. 2014;2014:1–13. Available from: http://dx.doi.org/10.1155/2014/910751
XIV. Anne Cathrine Staff, Fjeldstad HE, Fosheim IK, Moe K, Turowski G, Johnsen GM, et al. Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia. Am J Obstet Gynecol [Internet]. 2022;226(2):S895–906. Available from:
http://dx.doi.org/10.1016/j.ajog.2020.09.026
XV. Longo SA, Dola CP, Pridjian G. Preeclampsia and eclampsia revisited. South Med J [Internet]. 2003;96(9):891–9. Available from:
http://dx.doi.org/10.1097/01.SMJ.0000084385.85123.08
XVI. Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia: Figure 1. J Am Soc Nephrol [Internet]. 2007;18(8):2281–4. Available from: http://dx.doi.org/10.1681/asn.2007020255
XVII. Lambert G, Brichant JF, Hartstein G, Bonhomme V, Dewandre PY. Preeclampsia: an update. Acta Anaesthesiol Belg. 2014;65(4):137–49.
XVIII. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: Clinical issues and management. A Review. BMC Pregnancy Childbirth [Internet]. 2009;9(1). Available from:
http://dx.doi.org/10.1186/1471-2393-9-8
XIX. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Barry MJ, Davidson KW, et al. Screening for preeclampsia: US preventive services task force recommendation statement. JAMA [Internet]. 2017;317(16):1661. Available from:
http://dx.doi.org/10.1001/jama.2017.3439
XX. Zeisler H, Llurba E, Chantraine F, Vatish M, Anne Cathrine Staff, Sennström M, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med [Internet]. 2016;374(1):13–22. Available from:
http://dx.doi.org/10.1056/nejmoa1414838
XXI. Maulik D. Doppler ultrasound of the umbilical artery for fetal surveillance. Post TW, editor.
XXII. Amaral LM, Wallace K, Owens M, LaMarca B. Fisiopatología y manejo clínico actual de la preeclampsia. . Curr Hipertens Rep . 2017 ; 19 (8) : pág.61 . doi: 10.1007/s11906-017-0757-7 . | Abrir en Lectura por QxMD
XXIII. Ridder A, Giorgione V, Khalil A, Thilaganathan B. Preeclampsia: la relación entre el flujo sanguíneo de la arteria uterina y la función del trofoblasto . Revista Internacional de Ciencias Moleculares . 2019 ; 20 (13) : pág. 3263 .
doi: 10.3390/ijms20133263 . | Abrir en Lectura por QxMD
XXIV. Espinoza J, Kusanovic JP, Bahado-Singh R, et al . ¿Debería usarse la muesca bilateral de la arteria uterina en la evaluación del riesgo de preeclampsia, pequeño para la edad gestacional e hipertensión gestacional? . J Ultrasonido Med . 2010 ; 29 (7) : pág. 1103-15 . doi: 10.7863/jum.2010.29.7.1103 . | Abrir en Lectura por QxMD
XXV. Naoum EE, Leffert LR, Chitilian HV, Gray KJ, Bateman BT. Acute fatty liver of pregnancy. Anesthesiology [Internet]. 2019;130(3):446–61. Available from: http://dx.doi.org/10.1097/aln.0000000000002597
XXVI. Dey M, Kumar R, Narula GK, Vadhera A. Acute fatty liver of pregnancy. Med J Armed Forces India [Internet]. 2014;70(4):392–3. Available from: http://dx.doi.org/10.1016/j.mjafi.2012.06.013
XXVII. Dwivedi S, Runmei M. Retrospective study of seven cases with acute fatty liver of pregnancy. ISRN Obstet Gynecol [Internet]. 2013;2013:1–7. Available from:
http://dx.doi.org/10.1155/2013/730569
XXVIII. Nguyen KD, Sundaram V, Ayoub WS. Atypical causes of cholestasis. World J Gastroenterol [Internet]. 2014;20(28):9418–26. Available from: http://dx.doi.org/10.3748/wjg.v20.i28.9418
XXIX. Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol [Internet]. 2009;15(17):2049. Available from:
http://dx.doi.org/10.3748/wjg.15.2049
XXX. Post TW, editor. Drug doses for oral treatment of hypertension in pregnancy.
XXXI. Lam MC, Dierking E. Problemas de la Unidad de Cuidados Intensivos en eclampsia y síndrome HELLP . Revista Internacional de Enfermedades Críticas y Ciencias de las Lesiones . 2017 ; 7 (3) : pág. 136 . doi: 10.4103/ijciis.ijciis_33_17 . | Abrir en Lectura por QxMD
XXXII. Poon LC, Magee LA, Verlohren S, et al . Una revisión de la literatura y consejos de mejores prácticas para la estratificación del riesgo, el control y el tratamiento de la preeclampsia en el segundo y tercer trimestre . Revista Internacional de Ginecología y Obstetricia . 2021 ; 154 (T1) : págs. 3-31 . doi: 10.1002/ijgo.13763 .
XXXIII. Williams D. Long-term complications of preeclampsia. Semin Nephrol [Internet]. 2011;31(1):111–22. Available from:
http://dx.doi.org/10.1016/j.semnephrol.2010.10.010
XXXIV. Khan A, Department of Obstetrics & Gynecology, Burdwan Medical College, West Bengal, India, Ghosh A, Banerjee PK, Mondal TK. Analysis of the causes of maternal death in eclampsia. IOSR j dent med sci [Internet]. 2014;13(3):07–10. Available from: http://dx.doi.org/10.9790/0853-13360710
XXXV. Kattah AG, Garovic VD. The management of hypertension in pregnancy. Adv Chronic Kidney Dis [Internet]. 2013;20(3):229–39. Available from: http://dx.doi.org/10.1053/j.ackd.2013.01.014
XXXVI. Mostello D, Kallogjeri D, Tungsiripat R, Leet T. Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births. Am J Obstet Gynecol [Internet]. 2008;199(1):55.e1-55.e7. Available from:
http://dx.doi.org/10.1016/j.ajog.2007.11.058
XXXVII. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol [Internet]. 2008;112(2):359–72. Available from:
http://dx.doi.org/10.1097/aog.0b013e3181801d56
XXXVIII. August P. Preeclampsia: Prevention. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/preeclampsia-prevention
XXXIX. Pawelec M, Karmowski A, Karmowski M, Krzemieniewska J, Kulczycka A, Gabryś MS, et al. Inability to have children caused by recurrent HELLP syndrome in early pregnancies - implications for a review of literature. Adv Clin Exp Med. 2013;22(5):753–8.
XL. Tlaye KG, Endalfer ML, Kassaw MW, Gebremedhin MM, Aynalem YA. Preeclampsia management modalities and perinatal death: a retrospective study in Woldia general hospital. BMC Pregnancy Childbirth [Internet]. 2020;20(1). Available from: http://dx.doi.org/10.1186/s12884-020-02909-9
XLI. Tsokos M. Pathological features of maternal death from HELLP syndrome. In: Forensic Pathology Reviews. Totowa, NJ: Humana Press; 2004. p. 275–90.